|
GLOD4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.82409642945913E-13 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.47259981986281E-10 |
| Normal-vs-Stage2 |
7.844500E-02 |
| Normal-vs-Stage3 |
4.115000E-01 |
| Normal-vs-Stage4 |
9.704800E-01 |
| Stage1-vs-Stage2 |
1.611980E-01 |
| Stage1-vs-Stage3 |
1.376360E-02 |
| Stage1-vs-Stage4 |
4.727700E-02 |
| Stage2-vs-Stage3 |
4.443800E-01 |
| Stage2-vs-Stage4 |
2.885000E-01 |
| Stage3-vs-Stage4 |
6.680400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.1609827522725E-12 |
| Normal-vs-AfricanAmerican |
1.165810E-04 |
| Normal-vs-Asian |
6.106600E-01 |
| Caucasian-vs-AfricanAmerican |
1.175800E-01 |
| Caucasian-vs-Asian |
4.269200E-01 |
| AfricanAmerican-vs-Asian |
6.402800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.97530880541308E-12 |
| Normal-vs-Female |
8.583100E-04 |
| Male-vs-Female |
2.026000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.670400E-02 |
| Normal-vs-Extreme_Weight |
7.53330000047292E-07 |
| Normal-vs-Obese |
2.32199999999905E-05 |
| Normal-vs-Extreme_Obese |
1.059840E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.156400E-02 |
| Normal_Weight-vs-Obese |
1.212590E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.886600E-01 |
| Extreme_Weight-vs-Obese |
3.467400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.772400E-01 |
| Obese-vs-Extreme_Obese |
6.232200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.118000E-02 |
| Normal-vs-Age(41-60Yrs) |
1.32349997628012E-09 |
| Normal-vs-Age(61-80Yrs) |
1.98409999541127E-08 |
| Normal-vs-Age(81-100Yrs) |
5.094200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.019600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.312600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.032800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.307800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.178030E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.180000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
1.534440E-01 |
| Normal-VS-KIRP CIMP |
9.137200E-01 |
| Normal-VS-Unclassified PRCC |
3.085600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
7.78240000220976E-08 |
| Type1 PRCC-VS-KIRP CIMP |
3.063900E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.083700E-03 |
| Type2 PRCC-VS-KIRP CIMP |
5.162800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.035600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.306000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.314300E-02 |
| Normal-vs-N1 |
2.934400E-01 |
| Normal-vs-N2 |
2.40950000000018E-05 |
| N0-vs-N1 |
5.262200E-01 |
| N0-vs-N2 |
5.246300E-02 |
| N1-vs-N2 |
2.694000E-02 |
|
|
